Rosiglitazone-Induced Heart Remodelling Is Associated With Enhanced Turnover of Myofibrillar Protein and mTOR Activation

Journal of Molecular and Cellular Cardiology - United States
doi 10.1016/j.yjmcc.2009.04.011

Related search